Medipal Holdings
Medipal Holdings Corporation is a Japanese pharmaceutical and medical supply wholesaler distributing prescription drugs, medical devices, and cosmetics across Japan. The company operates through three business segments: Prescription Pharmaceuticals, distributing prescription drugs to hospitals and pharmacies, Cosmetics/Daily Necessities, and Veterinary/Food Products. Principal revenues derive from wholesale distribution margins on prescription medicines, diagnostic equipment, and consumer personal care goods provided directly to healthcare facilities and retailers. Core end markets serve hospitals, retail pharmacies, medical clinics, cosmetics retailers, and livestock farms across Japan. Medipal Holdings holds the market-leading position in Japan as one of the country's largest wholesale distributors of prescription pharmaceuticals and medical supplies. The corporation is headquartered in Tokyo, Japan, and its common stock trades on the Tokyo Stock Exchange.
8 of the funds FundTelligence covers report a position in Medipal Holdings.
- Legal name
- Medipal Holdings Corp
- Sector
- Health Care
- Country
- Japan
- Funds holding it
- 8
Funds holding Medipal Holdings
- Schroder ISF Global Sustainable Value — Schroders · 1.95 % (full portfolio disclosed, June 2026)
- Schroder ISF Global Recovery — Schroders · 1.42 % (full portfolio disclosed, June 2026)
- KLP AksjeGlobal Small Cap Flerfaktor — KLP · 0.29 % (full portfolio disclosed, June 2026)
- Mercer Global Small Cap Equity Fund — Mercer · 0.25 % (full portfolio disclosed, December 2025)
- Handelsbanken Global Högutdelande Criteria — Handelsbanken · 0.2 % (full portfolio disclosed, October 2026)
- Handelsbanken Global Utbytte — Handelsbanken · 0.2 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.03 % (partially disclosed portfolio, June 2026)
- DNB Global Enhanced Small Cap — DNB · 0.03 % (full portfolio disclosed, September 2026)